Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000406965

Medchemexpress LLC Mizolastine | 108612-45-9 | 99.8% | 1 ML
SDP

Catalog No. 5000406965
Encompass_Preferred

Mizolastine is an orally active, high affinity and specific peripheral histamine H1 receptor antagonist (second generation antihistamine). It effectively inhibits mRNA expression of VEGF165, VEGF120, TNF-α, and KC. Mizolastine can be used in studies of allergic rhinitis and chronic idiopathic urticaria. It is for research use only and not sold to patients.

  • Orally active compound
  • High affinity and specific peripheral histamine H1 receptor antagonist
  • Second generation antihistamine
  • Inhibits mRNA expression of VEGF165, VEGF120, TNF-α, and KC
  • Suitable for studies of allergic rhinitis and chronic idiopathic urticaria

Catalog No. 50-004-06965 Supplier Medchemexpress LLC Supplier No. HYB016410MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Mizolastine is an orally active, high affinity and specific peripheral histamine H1 receptor antagonist (second generation antihistamine). It effectively inhibits mRNA expression of VEGF165, VEGF120, TNF-α, and KC. Mizolastine can be used in studies of allergic rhinitis and chronic idiopathic urticaria. It is for research use only and not sold to patients.

  • Orally active compound
  • High affinity and specific peripheral histamine H1 receptor antagonist
  • Second generation antihistamine
  • Inhibits mRNA expression of VEGF165, VEGF120, TNF-α, and KC
  • Suitable for studies of allergic rhinitis and chronic idiopathic urticaria

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.